510(k) device
Indego(R)
Parker-Hannifin Corporation · Powered Exoskeleton (PHL, Class II) · First FDA decision Feb 26, 2016, newest Jan 31, 2018Mobility impairmentSpinal cord injury and paralysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
11
Naming "Indego"
MAUDE reports
3
Brand "Indego", since 2015
PubMed studies
18
Mentioning "Indego"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Indego(R)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Indego(R)510(k)
K173530 · Decided Jan 31, 2018 · 77 days after receipt
Device type: Powered Exoskeleton (PHL) · Physical Medicine & Rehabilitation
- Indego510(k)
K171334 · Decided Sep 8, 2017 · 123 days after receipt
Device type: Powered Exoskeleton (PHL) · Physical Medicine & Rehabilitation
- Indego510(k)
K152416 · Decided Feb 26, 2016 · 184 days after receipt
Device type: Powered Exoskeleton (PHL) · Physical Medicine & Rehabilitation
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Indego", any status and sponsor, newest update first.
- Gait Training Through a Novel Over-ground Wearable Robotic System in People With Pyramidal HemisyndromesActive, not recruiting
IRCCS San Raffaele RomaAcademic, hospital or other
NCT04559724 · 30 participants · Start Sep 1, 2020 · Primary completion Dec 2026
Device: Indego Therapy · For: Stroke; Brain Injuries, Traumatic; Brain Tumor Benign
Sites: Roma, Italy
Georgia Institute of TechnologyAcademic, hospital or other
NCT07128901 · 6 participants · Start Dec 10, 2025 · Primary completion May 19, 2026
Device: Ekso Indego Therapy; Wandercraft Atalante X · For: Spinal Cord Injuries
Sites: Atlanta, Georgia
- Health and Financial Impact on the Use of a Personal Exoskeleton in the Home and Community: a Case StudyEnrolling by invitation
Ekso BionicsNot on our public-company list
NCT07030322 · 5 participants (planned) · Start Aug 4, 2025 · Primary completion Sep 2027
Device: Overground Robotic Exoskeleton · For: Spinal Cord Injury
Sites: San Rafael, California
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Indego", and for the whole product code for context.
This brand
3 reports: 1 malfunction, 2 injury, 0 death
Whole product code PHL
57 reports: 7 malfunction, 50 injury, 0 death
Newest reports for this brand
- INDEGOInjury
3012247114-2020-00001 · Received Aug 26, 2020 · Event dated Jan 30, 2020
Device type: Powered Exoskeleton (PHL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bone Fracture(s); Swelling
- INDEGOInjury
3012247114-2020-00002 · Received Aug 26, 2020 · Event dated Jun 26, 2020
Device type: Powered Exoskeleton (PHL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bone Fracture(s); Swelling
- INDEGOMalfunction
PARKER HANNIFIN HUMAN MOTION AND CONTROL
3012247114-2017-00001 · Received Feb 9, 2017 · Event dated Dec 9, 2016
Device type: Powered Exoskeleton (PHL)
Device problem as coded: Component Missing
Patient problem as coded: No Consequences Or Impact To Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Indego"[tiab]. The summary above synthesizes these.
- Equity implications of electric bikesharing in Philadelphia.
Caspi O · GeoJournal · 2023
- Experimental Evaluation of Machine Learning Models for Gait Segmentation.
Strick JA, Wiebrecht JJ, Farris RJ, et al. · Annu Int Conf IEEE Eng Med Biol Soc · 2024
- Muscle model control of knee joint torque in a powered lower-body orthosis.
Hnat S, Nataraj R · Proc Inst Mech Eng H · 2023
- Overground robotic training effects on walking and secondary health conditions in individuals with spinal cord injury: systematic review.
Tamburella F, Lorusso M, Tramontano M, et al. · J Neuroeng Rehabil · 2022Research Support, Non-U.S. Gov't, Systematic Review
- Mobility Outcomes Following Five Training Sessions with a Powered Exoskeleton.
Hartigan C, Kandilakis C, Dalley S, et al. · Top Spinal Cord Inj Rehabil · 2015Research Support, Non-U.S. Gov't
- Machine-learned Adaptive Switching in Voluntary Lower-limb Exoskeleton Control: Preliminary Results.
Faridi P, Mehr JK, Wilson D, et al. · IEEE Int Conf Rehabil Robot · 2022Research Support, Non-U.S. Gov't
- Exoskeletons' design and usefulness evidence according to a systematic review of lower limb exoskeletons used for functional mobility by people with spinal cord injury.
Lajeunesse V, Vincent C, Routhier F, et al. · Disabil Rehabil Assist Technol · 2016Systematic Review
- Team IHMC at the 2020 Cybathlon: a user-centered approach towards personal mobility exoskeletons.
Peterson B, Daniel M, Subra Mani V, et al. · J Neuroeng Rehabil · 2022Research Support, Non-U.S. Gov't
- State-of-the-Art in Robotic Rehabilitation for Spinal Cord Injury Patients: A Literature Review.
Lee SH, Ko MJ, Lee YS, et al. · Korean J Neurotrauma · 2025Review
- A Unified Gait Phase Estimation and Control of Exoskeleton using Virtual Energy Regulator (VER).
Nasiri R, Dinovitzer H, Arami A · IEEE Int Conf Rehabil Robot · 2022Research Support, Non-U.S. Gov't
- Initial Outcomes from a Multicenter Study Utilizing the Indego Powered Exoskeleton in Spinal Cord Injury.
Tefertiller C, Hays K, Jones J, et al. · Top Spinal Cord Inj Rehabil · 2018Multicenter Study, Observational Study
- Risk management and regulations for lower limb medical exoskeletons: a review.
He Y, Eguren D, Luu TP, et al. · Med Devices (Auckl) · 2017Review
Other devices of this type
Also filed under product code PHL.
- Atalante XWandercraft SAS · 510(k) 2025
- ReWalk P6.0Re Walk Robotics , Ltd. · 510(k) 2023
- EksoNREkso Bionics, Inc. · 510(k) 2022
- HAL for Medical Use(Lower Limb type)Cyberdyne, Inc. · 510(k) 2020
- Ekso (version 1.1) and Ekso GT (version 1.2)Ekso Bionics, Inc. · 510(k) 2016
- Trexo TheoTrexo Robotics, Inc. · 510(k) 2026
- EveWandercraft SAS · 510(k) 2026
- ReWalk® 7 Personal Exoskeleton (50-20-0005)Rewalk Robotics Ltd. Dba Lifeward · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.